Patents by Inventor Ho Yin Li

Ho Yin Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230132557
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Application
    Filed: December 29, 2022
    Publication date: May 4, 2023
    Applicant: Scipio Life Sciences Limited
    Inventors: Wai Yip Thomas LEE, Chung Sing Daniel POON, Ka Lun LAI, Junzhe HUANG, Ho Yin LI
  • Patent number: 11571422
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Grant
    Filed: October 5, 2021
    Date of Patent: February 7, 2023
    Assignee: SCIPIO LIFE SCIENCES LIMITED
    Inventors: Wai Yip Thomas Lee, Chung Sing Daniel Poon, Ka Lun Lai, Junzhe Huang, Ho Yin Li
  • Publication number: 20220023297
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Application
    Filed: October 5, 2021
    Publication date: January 27, 2022
    Applicant: Aptorum Therapeutics Limited
    Inventors: Wai Yip Thomas LEE, Chung Sing Daniel POON, Ka Lun LAI, Junzhe HUANG, Ho Yin LI
  • Patent number: 11166952
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Grant
    Filed: November 27, 2020
    Date of Patent: November 9, 2021
    Assignee: APTORUM THERAPEUTICS LIMITED
    Inventors: Wai Yip Thomas Lee, Chung Sing Daniel Poon, Ka Lun Lai, Junzhe Huang, Ho Yin Li
  • Publication number: 20210161892
    Abstract: The present invention provides a composition and method for preventing the growth of and/or treating cancerous tumors and/or delaying onset of cancer from tumor-initiating cells. The composition includes an effective amount of a compound of Formula (I) or Formula (II): or any pharmaceutically acceptable salt thereof. The composition is administered alone or in combination with one or more chemotherapeutic agents, biological agents and/or anticancer agents. The method may include administering the composition of the present invention with or without the chemotherapeutic, biological, or other cancer treatment agent to a subject in need thereof intravenously, parenterally, nasally, topically or locally, orally, or by liposome, implant or via vessel-targeted nanosuspension delivery.
    Type: Application
    Filed: November 27, 2020
    Publication date: June 3, 2021
    Applicant: Aptorum Therapeutics Limited
    Inventors: Wai Yip Thomas LEE, Chung Sing Daniel POON, Ka Lun LAI, Junzhe HUANG, Ho Yin LI
  • Publication number: 20190029970
    Abstract: The present invention provides fatty acid-conjugated nanoparticles and methods of making and using the same. Methods for improving delivery of therapeutic agents (e.g., drugs) contained within the fatty acid conjugated nanoparticles to the central nervous system (e.g., across the blood brain barrier) are disclosed.
    Type: Application
    Filed: July 26, 2018
    Publication date: January 31, 2019
    Inventors: Wai Yip LEE, Ho Yin Li
  • Publication number: 20130132489
    Abstract: A system incorporating techniques described in this paper includes a bubble server capable of facilitating the creation of location-based virtual networks (“bubbles”) that bubble clients can join. Bubble clients can be implemented on mobile devices that can contact the bubble server via a network connection.
    Type: Application
    Filed: January 23, 2012
    Publication date: May 23, 2013
    Inventors: Sheng Chao Huang, Ho Yin Li